Inovio Pharmaceuticals Company Profile (NASDAQ:INO)

About Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. (Inovio) is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), influenza, Ebola, Middle East respiratory syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, the Company has a pipeline of pre-clinical and clinical stage products that have generated in vivo (in the body) immune responses.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Exchange: NASDAQ
• Symbol: INO
• CUSIP:

Key Metrics:

• Previous Close: $9.44
• 50 Day Moving Average: $9.09
• 200 Day Moving Average: $9.45
• 52-Week Range: $4.50 - $11.69
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -7.80
• P/E Growth: 0.00
• Market Cap: $709.00M
• Outstanding Shares: 73,548,000
• Beta: 2.89

Profitability:

• Net Margins: -88.19%
• Return on Equity: -22.29%
• Return on Assets: -18.21%

Debt:

• Current Ratio: 4.17%
• Quick Ratio: 4.17%

Additional Links:

• Visit Inovio Pharmaceuticals' Official Website
• View INO on Google Finance
• View INO on Yahoo Finance
• View INO's Company Profile on Reuters
• Search for Inovio Pharmaceuticals Inc. on Google

Companies Related to Inovio Pharmaceuticals:

• FibroGen (NASDAQ:FGEN)
• Pacira Pharmaceuticals (NASDAQ:PCRX)
• Omnicell (NASDAQ:OMCL)
• Magellan Health Services (NASDAQ:MGLN)
• Portola Pharmaceuticals (NASDAQ:PTLA)
• Cempra (NASDAQ:CEMP)
• Coherus BioSciences (NASDAQ:CHRS)
• Supernus Pharmaceuticals (NASDAQ:SUPN)
• Glaukos Corp. (NYSE:GKOS)
• TherapeuticsMD (NYSEMKT:TXMD)

Earnings

Earnings History for Inovio Pharmaceuticals (NASDAQ:INO)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/7/2016
8/8/2016	Q2	($0.21)	($0.26)	$4.95 million	$6.20 million	View	N/A
5/9/2016	Q1	($0.14)	($0.11)	$4.75 million	$8.10 million	View	N/A
3/14/2016	Q4	($0.20)	($0.25)	$6.96 million	$5.94 million	View	Listen
11/9/2015	Q3	$0.04	$0.07	$1.84 million	$24.18 million	View	N/A
8/10/2015	Q215	($0.13)	($0.10)	$5.52 million	$5.30 million	View	Listen
5/11/2015	Q1	($0.11)	($0.18)	$7.04 million	$5.20 million	View	Listen
3/16/2015	Q414	($0.10)	($0.12)	$5.24 million	$2.50 million	View	N/A
11/10/2014	Q314	($0.14)	($0.12)	$5.60 million	$1.80 million	View	N/A
8/11/2014	Q214	($0.19)	($0.18)	$1.80 million	$3.80 million	View	N/A
5/12/2014	Q114	($0.04)	($0.05)	$1.41 million	$2.40 million	View	N/A
3/17/2014	Q413	($0.03)	($0.04)	$1.36 million	$1.70 million	View	N/A
11/11/2013	Q3	($0.02)	($0.16)	$2.99 million	$9.50 million	View	Listen
11/7/2012	Q312	($0.05)	($0.05)	$2.07 million		View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Inovio Pharmaceuticals (NASDAQ:INO)

Dividends

Dividend History for Inovio Pharmaceuticals (NASDAQ:INO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Inovio Pharmaceuticals (NASDAQ:INO)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
8/29/2016	Niranjan Sardesai	COO	Sell	21,800	$9.30	$202,740.00
6/28/2016	Morton Collins	Director	Buy	10,000	$9.13	$91,300.00
5/18/2016	Simon X Benito	Director	Sell	6,250	$10.37	$64,812.50
4/15/2016	Morton Collins	Director	Buy	68,400	$9.52	$651,168.00
9/30/2015	Niranjan Sardesai	COO	Buy	4,000	$5.50	$22,000.00
8/14/2015	Simon X Benito	Director	Buy	6,000	$7.21	$43,260.00
4/13/2015	Angel Cabrera	Director	Buy	8,000	$9.53	$76,240.00
10/9/2014	Peter Kies	CFO	Buy	3,960	$10.10	$39,996.00
8/21/2014	Morton Collins	Director	Buy	8,000	$10.01	$80,080.00
8/20/2014	Morton Collins	Director	Buy	40,600	$9.74	$395,444.00
8/12/2014	Jong Joseph Kim	CEO	Buy	250,000	$9.06	$2,265,000.00
8/12/2014	Niranjan Sardesai	COO	Buy	2,550	$8.70	$22,185.00
4/15/2014	Jong Joseph Kim	CEO	Buy	25,000	$2.25	$56,250.00
11/13/2013	Morton Collins	Director	Buy	254,500	$1.82	$463,190.00
4/16/2013	Mark Bagarazzi	Insider	Buy	60,000	$0.56	$33,600.00
4/2/2013	Jong Joseph Kim	CEO	Buy	90,000	$0.50	$45,000.00
3/22/2013	Angel Cabrera	Director	Buy	40,000	$0.54	$21,600.00
3/20/2013	Jong Joseph Kim	CEO	Buy	60,000	$0.53	$31,800.00
3/20/2013	Niranjan Sardesai	COO	Buy	25,000	$0.53	$13,250.00
1/15/2013	Morton Collins	Director	Buy	100,000	$0.67	$67,000.00
11/14/2012	Austin W & Greenhouse Da Marxe	Major Shareholder	Sell	622,550	$0.53	$329,951.50
8/15/2012	Angel Cabrera	Director	Buy	75,000	$0.59	$44,250.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Inovio Pharmaceuticals (NASDAQ:INO)

Date	Headline
	Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2016 - New Market Report (NASDAQ:INO) reports.pr-inside.com - September 27 at 10:15 AM
	Biotech news that matter for investors: Kite Pharma, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:INO) voiceregistrar.com - September 23 at 5:19 PM
	Analysts Valuations For Two Stocks: Inovio Pharmaceuticals Inc (NASDAQ:INO), Bill Barrett Corporation (NYSE:BBG) - The Voice Registrar (NASDAQ:INO) voiceregistrar.com - September 23 at 8:35 AM
	Biotech Stocks Worth a Closer Look: Inovio Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:INO) voiceregistrar.com - September 22 at 3:41 PM
	Hot Biotech Stocks Recap: Cerus Corporation (NASDAQ:CERS), Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - The Voice Registrar (NASDAQ:INO) voiceregistrar.com - September 21 at 9:49 AM
	Analysts Valuations For Two Stocks: Abraxas Petroleum Corp ... - The Voice Registrar (NASDAQ:INO) voiceregistrar.com - September 14 at 5:45 PM
	HC Stocks to Path= Inovio Pharmaceuticals Inc (INO), Palatin Technologies, Inc. (NYSEMKT:PTN) - share market updates (press release) (NASDAQ:INO) sharemarketupdates.com - September 14 at 5:45 PM
	Inovio Pharmaceuticals, Inc. in 3 Charts - Motley Fool (NASDAQ:INO) www.fool.com - September 14 at 5:45 PM
	Inovio Pharmaceuticals, Inc. – Value Analysis (NASDAQ:INO) : September 14, 2016 (NASDAQ:INO) www.capitalcube.com - September 14 at 5:45 PM
	Inovio’s Zika Vaccine Bags Tech Award (INO) (NASDAQ:INO) www.investopedia.com - September 14 at 9:52 AM
	Inovio Pharmaceuticals, Inc. in 3 Charts (NASDAQ:INO) www.fool.com - September 13 at 4:51 PM
	Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : INO-US : September 13, 2016 (NASDAQ:INO) www.capitalcube.com - September 13 at 10:28 AM
	Inovio's Race to Kill the Zika Virus (INO) (NASDAQ:INO) www.investopedia.com - September 12 at 5:31 PM
	The Race to Kill the Zika Virus (INO) (NASDAQ:INO) www.investopedia.com - September 12 at 5:31 PM
	Inovio’s Zika Vaccine Selected As 2016 Technology Breakthrough (NASDAQ:INO) www.publicnow.com - September 12 at 10:22 AM
	Inovio Pharmaceuticals, Inc Pipeline Review, Market Share, Size and Clinical trial 2016 - 2020 - Medgadget (blog) (NASDAQ:INO) www.medgadget.com - September 10 at 10:01 AM
	HC Stocks Updates= Teva Pharmaceutical Industries Ltd (TEVA), Inovio Pharmaceuticals Inc (NASDAQ:INO) - share market updates (press release) (NASDAQ:INO) sharemarketupdates.com - September 9 at 10:22 AM
	Looking Ahead for Inovio Pharmaceuticals, Inc. (NASDAQ:INO); Are ... - Frisco Fastball (NASDAQ:INO) friscofastball.com - September 8 at 5:32 PM
	2 Biotech Stocks News And Price Trends: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Cempra, Inc. (NASDAQ:CEMP) - The Voice Registrar (NASDAQ:INO) voiceregistrar.com - September 7 at 9:05 AM
	Stocks Dominating Wall Street: Mylan N.V. (NASDAQ:MYL), Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Wise Report (press release) (blog) (NASDAQ:INO) streetwisereport.com - September 6 at 10:23 AM
	Why Inovio Pharmaceuticals Isn't the Best Zika Stock Right Now (NASDAQ:INO) www.fool.com - September 5 at 10:00 AM
	Inovio Pharmaceuticals, Inc. Pipeline Review, Market Share, Strategy, Size and Forecast 2016 - 2020 - Medgadget (blog) (NASDAQ:INO) www.medgadget.com - September 3 at 10:11 AM
	Hot Stock Alert - Inovio Pharmaceuticals, Inc.'s (INO) - Hot Stocks Point (NASDAQ:INO) www.hotstockspoint.com - September 2 at 5:36 PM
	How The Zika Virus Spread While Congress Was Out On Recess - Benzinga (NASDAQ:INO) www.benzinga.com - September 2 at 5:36 PM
	How The Zika Virus Spread While Congress Was Out On Recess (NASDAQ:INO) finance.yahoo.com - September 2 at 5:36 PM
	Pennsylvania firm launches experimental Zika vaccine clinical trial in Puerto Rico (NASDAQ:INO) www.sfltimes.com - September 1 at 5:33 PM
	Takeda Gets Up to $312 Million in U.S. Funding for Zika Vaccine (NASDAQ:INO) www.bloomberg.com - September 1 at 5:33 PM
	Inovio Pharmaceuticals to Present at Upcoming Investment Conferences (NASDAQ:INO) finance.yahoo.com - September 1 at 5:33 PM
	Technical Roundup on Biotech Stocks -- Keryx Biopharma, Inovio Pharma, Seattle Genetics, and Arrowhead Pharma - PR Newswire (press release) (NASDAQ:INO) www.prnewswire.com - August 31 at 10:27 AM
	Active biotech company shares in the news: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Raptor Pharmaceuticals Corp ... - The Voice Registrar (NASDAQ:INO) voiceregistrar.com - August 31 at 10:27 AM
	Zika vaccine: Inovio starts clinical study in Puerto Rico (NASDAQ:INO) outbreaknewstoday.com - August 30 at 8:50 AM
	Technical Roundup on Biotech Stocks -- Keryx Biopharma, Inovio Pharma, Seattle Genetics, and Arrowhead Pharma (NASDAQ:INO) www.kait8.com - August 30 at 8:50 AM
	Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : INO-US : August 30, 2016 (NASDAQ:INO) www.capitalcube.com - August 30 at 8:50 AM
	Inovio Stock Up as Second Zika Virus Vaccine Study Begins (NASDAQ:INO) finance.yahoo.com - August 30 at 8:50 AM
	Buzz Stocks: Mylan NV, Inovio Pharmaceuticals Inc, and Herbalife Ltd. - Schaeffers Research (blog) (NASDAQ:INO) www.schaeffersresearch.com - August 29 at 5:30 PM
	Inovio Pharma (INO) Commences Zika Vaccine Study in Puerto Rico - StreetInsider.com (NASDAQ:INO) www.streetinsider.com - August 29 at 5:30 PM
	Pennsylvania firm launches Zika vaccine trial in Puerto Rico (NASDAQ:INO) finance.yahoo.com - August 29 at 5:30 PM
	Inovio (INO) Stock Climbs, Launches Zika Vaccine Trial (NASDAQ:INO) www.thestreet.com - August 29 at 5:30 PM
	Inovio: Let's Hear It For Zika! (NASDAQ:INO) blogs.barrons.com - August 29 at 5:30 PM
	Inovio launches second human study of potential Zika vaccine in Puerto Rico (NASDAQ:INO) www.bizjournals.com - August 29 at 5:30 PM
	BRIEF-Inovio launches Zika vaccine trial (NASDAQ:INO) www.reuters.com - August 29 at 10:10 AM
	Inovio Unveils Zika Vaccine Trial In Midst Of Puerto Rico Epidemic (NASDAQ:INO) www.rttnews.com - August 29 at 10:10 AM
	Inovio Pharma (INO) Commences Zika Vaccine Study in Puerto Rico (NASDAQ:INO) www.streetinsider.com - August 29 at 10:10 AM
	Inovio launches Zika vaccine trial in Puerto Rico (NASDAQ:INO) www.marketwatch.com - August 29 at 10:10 AM
	Inovio Launches Zika Vaccine Trial in Midst of Puerto Rico Epidemic to Explore Early Signals of Vaccine Efficacy (NASDAQ:INO) www.nasdaq.com - August 29 at 10:10 AM
	3 Stocks to Watch on Monday: Ford Motor Company (F), General Motors Company (GM), Inovio Pharmaceuticals Inc (INO) (NASDAQ:INO) investorplace.com - August 29 at 8:28 AM
	Inovio Expands Ebola Vaccine Trial (NASDAQ:INO) jutiagroup.com - August 25 at 10:39 AM
	Inovio Expands Ebola Vaccine Trial INO (NASDAQ:INO) www.investorideas.com - August 25 at 10:39 AM
	Inovio Pharmaceuticals, Inc. (INO) - Strategic and Financial SWOT Analysis Review (NASDAQ:INO) emailwire.com - August 24 at 5:31 PM
	Interesting INO Put And Call Options For October 21st (NASDAQ:INO) www.stockoptionschannel.com - August 23 at 10:01 AM

Social

Inovio Pharmaceuticals (NASDAQ:INO) Chart for Tuesday, September, 27, 2016